BOSTON, Aug. 18 (UPI) -- A Massachusetts startup company says it will release the genome sequence of marijuana to promote understanding of its therapeutic potential.
Kevin McKernan, founder of Medicinal Genomics in Marblehead, said the medicinal marijuana industry could use the data to offer new, better kinds of cannabis designed to target patients' specific conditions.